BFRIW (Biofrontera Inc. Warrants)

Insider Trading Activity

Every open-market purchase and sale reported by BFRIW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
43
most recent
Open-Market Buys
1
code P
Sales
0
code S
Reporting Insiders
3
current holders
BFRIW — Recent Form 4 Transactions (latest 2026-03-06)
FiledInsiderRole TypeSharesValue
2026-03-06 JOHN J III BORER Director A
2026-03-06 George Patrick Jones Chief Commercial Officer A
2026-03-06 Eugene Frederick Leffler Chief Financial Officer M
2026-03-06 Heikki Lanckriet Director A
2026-03-06 Hermann Luebbert CEO & Chairman M
2026-03-06 Kevin Daniel Weber Director A
2026-03-06 Beth J. Hoffman Director A
2025-09-18 Biofrontera AG Director Buy
2025-09-16 JOHN J III BORER Director A
2025-09-16 Heikki Lanckriet Director A
2025-09-16 Kevin Daniel Weber Director A
2025-09-16 Hermann Luebbert CEO & Chairman M
2025-09-16 George Patrick Jones Chief Commercial Officer A
2025-09-16 Beth J. Hoffman Director A
2025-09-16 Eugene Frederick Leffler Chief Financial Officer M
2024-07-16 Hermann Luebbert CEO & Chairman A
2024-07-16 Heikki Lanckriet Director A
2024-07-16 JOHN J III BORER Director A
2024-07-16 Beth J. Hoffman Director A
2024-07-16 Eugene Frederick Leffler Chief Financial Officer A
2024-07-16 Kevin Daniel Weber Director A
2024-05-22 Hermann Luebbert CEO & Exec. Chairman M
2023-05-22 Erica L. Monaco Chief Executive Officer M
2023-05-22 Hermann Luebbert Executive Chairman M
2023-01-12 Eugene Frederick Leffler Chief Financial Officer A
2022-09-19 Hermann Luebbert Executive Chairman M
2022-09-19 Erica L. Monaco Chief Executive Officer M
2022-06-06 Kevin Daniel Weber Director A
2022-06-06 Beth J. Hoffman Director A
2022-06-06 Loretta M. Wedge Director A
2022-06-06 JOHN J III BORER Director A
2022-05-26 Beth J. Hoffman Director A
2022-05-26 Loretta M. Wedge Director A
2022-05-26 Hermann Luebbert Executive Chairman A
2022-05-26 JOHN J III BORER Director A
2022-05-26 Erica F. Gates Senior Director Finance A
2022-05-26 Kevin Daniel Weber Director A
2022-05-26 Erica L. Monaco Chief Executive Officer A
2022-01-19 Erica L. Monaco Chief Executive Officer A
2022-01-19 Erica F. Gates Controller A
2022-01-19 Hermann Luebbert Executive Chairman A
2021-12-13 Erica F. Gates Controller A
2021-12-13 Erica L. Monaco Chief Executive Officer A
BFRIW — Current Insider Holders
InsiderRole Shares HeldValue
CEO & Chairman 290,211
Chief Financial Officer 175,000
Chief Executive Officer 133,025
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the BFRIW quote page; the site-wide leaderboard is on the insider transactions hub.